Customization: | Available |
---|---|
Assay Time: | 15 Minutes |
Delivery Time: | 3~5days After Get Payment |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
INTENDED USE
PRINCIPLE
The Dengue NS1 Rapid Test is a qualitative membrane - based immunoassay for the detection of Dengue NS1 antigen in whole blood, serum, or plasma. During testing, the specimen reacts with anti - Dengue NS1 antibody - colloidal gold conjugate in the test strip. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti - Dengue NS1 antibody in test line region. If the specimen contains Dengue virus NS1, a colored line will appear in test line region. If the specimen does not contain Dengue virus NS1, no colored line will appear in the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.
Materials Provided
|
|
|
|
Allow the test device,specimen, buffer, and/or controls to reach room temperature(10-30°C) prior to testing.
1. Bring the pouch to room temperature before opening. Remove the test device from the sealed pouch and use it as soon as possible.Hangzhou Immuno Biotech Co., Ltd is the founding company of the Immuno Group. In its early years, our team developed a series of proteins and rapid test kits for the in vitro diagnostic (IVD) industry. Over time, Immuno has established itself as a trusted R&D partner and reliable supplier of veterinary rapid test products.Through persistent dedication and continuous investment in the design and development of IVD reagents and test kits, we have achieved significant milestones in recent years-particularly in veterinary diagnostics.
Moving forward, Hangzhou Immuno Biotech Co., Ltd. will expand its focus into human medical diagnostics, specializing in:Rapid tests for vector-borne diseases (VBDs), Rapid tests for sexually transmitted diseases (STDs), Rapid tests for respiratory system diseases, Rapid tests for digestive system diseases. Additionally, leveraging our strong R&D capabilities, we will intensify efforts in diagnosing neglected tropical diseases (NTDs).Immuno remains committed to advancing diagnostic solutions for both human health and the natural world.